Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Finerenone increases the likelihood of improved KDIGO risk category in patients with CKD and type 2 diabetes: An analysis from FIDELITY.
Journal: Journal of diabetes and its complications
Published: June 16, 2025
Shifts in KDIGO CKD risk groups with empagliflozin: Kidney-protection from SGLT2 inhibition across the spectrum of risk.
Journal: Journal of diabetes and its complications
Published: July 11, 2023
Showing 1-2 of 2
Last Updated: 09/26/2026